中文名:Moexipril HCl
英文名:Moexipril HCl
英文別名:RS-10085;(3S)?- 2-?[(2S)?-?2-?[[(1S)?-?1-?(ethoxycarbonyl)?-?3-?phenylpropyl]?amino]?-?1-?oxopropyl]?-?1,?2,?3,?4-?tetrahydro-?6,?7-?dimethoxy-3-?isoquinolinecarboxyl?ic acid,hydrochloride (1:1)
純度:10mM in DMSO
貨號:M409052
包裝:1ml
Cas號:82586-52-5
存儲溫度:-80℃儲存
產(chǎn)品介紹:
Information
Moexipril HCl (RS-10085) is a potent orally active nonsulfhydrylangiotensin converting enzyme (ACE)inhibitor, used for the treatment of hypertension and congestive heart failure.
In?vitro
Moexipril dose-dependently reduces the percentage of damaged neurons, as well as mitochondrial reactive oxygen species generation induced by glutamate, staurosporine or Fe2+/3+. Moexipril and enalapril attenuates staurosporine-induced neuronal apoptosis as determined by nuclear staining with Hoechst 33258.
In?vivo
Moexipril (0.3 mg/kg) significantly reduces brain damage after focal ischemia as compared to control mice. Moexipril (0.01 mg/kg) is able to reduce the infarct volume in the rat model after focal cerebral ischemia. Moexipril reduces blood pressure after the first week of treatment but it has no apparent effect on either the proximal tibial metaphysis or the tibial shaft in ovariectomized (OVX) spontaneously hypertensive rats (SHR). Moexipril combined with hydrochlorothiazide (HCTZ) exhibits a much more potent hypotensive effect and has the same effect on bone mass and dynamic end-points as HCTZ alone. Moexiprilat exhibits a higher inhibitory potency than enalaprilat against both plasma ACE and purified ACE from rabbit lung. Moexipril (0.1-30 mg/kg/day) lowers blood pressure and differentially inhibits ACE activity in plasma, lung, aorta, heart and kidney in a dose-dependent fashion. Moexipril (10 mg/kg/day) leads to comparable decreases in blood pressure, inhibition of plasma ACE and reduction of plasma angiotensinogen and to a similar attenuation of the pressor responses to angiotensin I and potentiation of the depressor responses to bradykinin.
Cell?Data
cell?lines:
Concentrations:
Incubation?Time:
Powder?Purity:≥99%
查看阿拉丁官網(wǎng)此產(chǎn)品相關對應頁面:https://www.aladdin-e.com/zh_cn/M409052.html
關鍵字: RS-10085;(3S)?- 2-?[(2S)?-?2-?[[(1S)?-?1-?(ethoxycarbonyl)?-?3-?phenylpropyl]?amino]?-?1-?oxopropyl]?-?1,?2,?3,?4-?tetrahydro-?6,?7-?dimethoxy-3-?isoquinolinecarboxyl?ic acid,hydrochloride (1:1)
上海阿拉丁生化科技股份有限公司是A股上市公司((股票代碼:688179),專注于科研試劑的研發(fā)、生產(chǎn)和銷售,已陸續(xù)建立多個工廠和研發(fā)中心。作為領軍企業(yè),阿拉丁始終堅持質(zhì)量第一,連續(xù)13年被評為“最受歡迎試劑品牌”。
阿拉丁目前常備庫存試劑產(chǎn)品品種超過7萬種,SKU總數(shù)超過46萬,產(chǎn)品線涵蓋了化學試劑、生化試劑、藥靶配體、蛋白質(zhì)和抗體等多個領域,是國內(nèi)少數(shù)化學試劑到生物試劑全面發(fā)展的國產(chǎn)試劑品牌,產(chǎn)品同步發(fā)布在我們國內(nèi)外電商平臺。